Hirota, Morihisa http://orcid.org/0000-0001-5682-0911
Shimosegawa, Tooru
Kitamura, Katsuya
Takeda, Kazunori
Takeyama, Yoshifumi
Mayumi, Toshihiko
Ito, Tetsuhide
Takenaka, Mamoru
Iwasaki, Eisuke
Sawano, Hirotaka
Ishida, Etsuji
Miura, Shin
Masamune, Atsushi
Nakai, Yousuke
Mitoro, Akira
Maguchi, Hiroyuki
Kimura, Kenji
Sanuki, Tsuyoshi
Ito, Tetsuya
Haradome, Hiroki
Kozaka, Kazuto
Gabata, Toshifumi
Kataoka, Keisho
Hirota, Masahiko
Isaji, Shuji
Nakamura, Ryoji
Yamagiwa, Koki
Kayaba, Chie
Ikeda, Koji
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP15lk0103015)
Japan Agency for Medical Research and Development (JP16lk0103015)
Article History
Received: 29 August 2019
Accepted: 11 November 2019
First Online: 22 November 2019
Compliance with ethical standards
:
: This trial was conducted as an investigator-initiated and -driven study and was supported by a subsidy from the Japan Agency for Medical Research and Development (AMED). There were no conflicts of interest involving companies that developed the study drug and other protease inhibitors.